| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.08. | Range Impact GAAP EPS of -$0.02, revenue of $1.1M | 1 | Seeking Alpha | ||
| RANGE IMPACT Aktie jetzt für 0€ handeln | |||||
| 12.08. | Range Impact, Inc.: Range Impact Reports 2Q 2026 Financial Results | 88 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact" or the "Company"), a public company dedicated to acquiring, reclaiming, and redeveloping legacy coal... ► Artikel lesen | |
| 12.08. | RANGE IMPACT, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.07. | Range Impact, Inc.: Range Impact Announces Vin Ferrara, MD, MBA, Has Joined the Company as Vice President, Real Estate | 518 | GlobeNewswire (Europe) | CLEVELAND, OHIO, July 08, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact" or the "Company"), a public company dedicated to acquiring, reclaiming and repurposing former industrial... ► Artikel lesen | |
| 01.07. | Range Impact, Inc.: Range Impact and C2 Ventures Launch AI Infrastructure Platform on 9,000-Acre West Virginia Energy Corridor | 2 | GlobeNewswire (USA) | ||
| 01.07. | RANGE IMPACT, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.06. | Range Impact, Inc.: Range Impact Announces $10 Million Investment from Tacora Capital | 3 | GlobeNewswire (USA) | ||
| 03.06. | RANGE IMPACT, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 28.05. | Range Impact, Inc.: Range Impact Announces West Virginia Attorney and Business Advisor Michael Simon Has Joined the Company as a Strategic Advisor | 1 | GlobeNewswire (USA) | ||
| 18.05. | Range Impact GAAP EPS of -$0.02, revenue of $0.92M | 1 | Seeking Alpha | ||
| 15.05. | Range Impact, Inc.: Range Impact Reports 1Q 2026 Financial Results | 195 | GlobeNewswire (Europe) | CLEVELAND, OHIO, May 15, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact" or the "Company"), a public company dedicated to acquiring, reclaiming and repurposing distressed coal... ► Artikel lesen | |
| 15.05. | RANGE IMPACT, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.05. | RANGE IMPACT, INC. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 31.03. | Range Impact reports FY results | 1 | Seeking Alpha | ||
| 31.03. | Range Impact, Inc.: Range Impact Reports Full Year 2025 Financial Results | 527 | GlobeNewswire (Europe) | CLEVELAND, OHIO, March 30, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact" or the "Company"), a public company dedicated to acquiring, reclaiming and repurposing distressed... ► Artikel lesen | |
| 07.01. | Range Impact, Inc.: Range Impact Announces Two Major Land Acquisitions in Kentucky and Sale of Abandoned Mine Land Services Business | 233 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public company dedicated to acquiring, reclaiming and repurposing distressed... ► Artikel lesen | |
| 14.11.25 | Range Impact, Inc.: Range Impact Reports 3Q 2025 Financial Results | 284 | GlobeNewswire (Europe) | Cleveland, Ohio, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public impact investing company dedicated to acquiring, reclaiming and repurposing... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 34,800 | +0,29 % | Pharma trifft KI: Anthropic an Bord: Novo will neue Wirkstoffe schneller entwickeln | © Foto: Christian Schultz/dpaNovo Nordisk will neue Medikamente schneller entwickeln und setzt dafür auf Anthropic. Die KI-Modelle sollen Forschung und Softwareentwicklung vorantreiben Enthaltene Werte:... ► Artikel lesen | |
| AURORA CANNABIS | 3,506 | +4,04 % | Curaleaf Holdings, Inc.: Curaleaf Submits Application to Alberta Securities Commission to Halt Aurora Cannabis' ATM Program During Pending Offer | Argues Aurora's share issuances are an improper and abusive defensive tactic that dilutes shareholders and interferes with consideration of Curaleaf's premium offer
Aurora's... ► Artikel lesen | |
| CANOPY GROWTH | 0,792 | -1,86 % | Canopy Growth Reports Q1 2027 Results: Full Earnings Call Transcript | ||
| TILRAY BRANDS | 3,560 | +2,30 % | Will Tilray Brands Stock Take Off Before the End of 2026? | ||
| VERTEX PHARMACEUTICALS | 445,70 | +0,72 % | Olympic skier Lindsey Vonn joins up with Vertex for pain campaign | ||
| CRONOS GROUP | 2,888 | -0,89 % | Cronos Group Inc.: Cronos to Host 2026 Investor Day at its Cronos GrowCo Facility in Kingsville, Ontario | ||
| DIGICANN VENTURES | 0,005 | 0,00 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| EYEPOINT | 3,580 | +6,55 % | EyePoint, Inc.: EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | ||
| ORGANIGRAM GLOBAL | 0,963 | +7,60 % | Organigram Global Inc.: Organigram Global treibt die Integration der Sanity Group unter einer einheitlichen globalen Betriebsstruktur voran | Führung, operatives Geschäft und Marktentwicklung werden über eine globale Plattform aufeinander abgestimmt, die Kanada mit Deutschland und anderen wichtigen internationalen Märkten verbindet
Die... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 6,330 | 0,00 % | Green Thumb Industries extends share buyback program with $50M authorization | ||
| NOVERIS HEALTH SCIENCES | 0,054 | -11,57 % | Noveris Health Sciences Inc.: Noveris Health Sciences Announces Results of 2026 Annual General and Special Meeting | Vancouver, British Columbia--(Newsfile Corp. - September 9, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") announces the results of its annual... ► Artikel lesen | |
| SANTHERA PHARMACEUTICALS | 17,080 | +1,18 % | Santhera Pharmaceuticals Holding AG: Santhera erweitert Vereinbarung mit Biomedica zur Ausweitung des Vertriebs von AGAMREE (Vamorolon) in Zentralasien und im Kaukasus | Pratteln, Schweiz, 13. Juli 2026 - Santhera Pharmaceuticals (SIX: SANN) gibt heute die Erweiterung seiner exklusiven Vertriebsvereinbarung mit Biomedica für AGAMREE (Vamorolon) bekannt. Die Partnerschaft... ► Artikel lesen | |
| NEKTAR THERAPEUTICS | 58,76 | +0,55 % | Nektar Therapeutics Announces Second Quarter 2026 Financial Results | SAN FRANCISCO, Aug. 13, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on development of novel immunology... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 9,194 | -2,71 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for TONMYA | New agreement, effective January 1, 2027, to add approximately 9 million Medicare lives (16% of approximately 55 million Medicare lives in the U.S.) On top of two previously announced major commercial... ► Artikel lesen | |
| AMARIN | 11,600 | -1,69 % | Amarin Corporation plc: Amarin Reports 2026 Second Quarter Financial Results Demonstrating Early Success of Fully Partnered International Commercial Strategy and Continued Leading U.S. Market Presence | Q2 2026 Results Highlight Global Volume Growth, Lower Operating Expenses and Positive Cash Flow For Full Year 2026, Company Expects Continued Growth in International Markets, Maintenance of VASCEPA's... ► Artikel lesen |